General Information
Version
5.1
Revision date
2025-03-20
Product name
Recombinant human insulin 0.5%
1.2.1 Relevant identified uses
Suitable for GMP manufacturing
1.2.2. Uses advised against
Not for human or animal in vivo or diagnostic use
Emergency telephone
+41 61 313 94 94
Icons in SDS
Company Information
company name
Lonza Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
sds@lonza.com
Section 2
SECTION 2: Hazards identification
(29 CFR 1910.1200) GHS Classification
2.2 Label elements
No hazard pictogram, no signal word, no hazard statement(s), no precautionary statement(s) required.
2.3 Other hazards
Insulin: may cause hypoglycaemia. Insulin is inactivated in the gastro-intestinal tract when ingested.
2.1 Classification of the substance or mixture
Not a hazardous substance or mixture according to US Regulation 29 CFR 1910.1200 and the Canadian HPA.
